Page last updated: 2024-11-02

oxyphenbutazone and Cardiovascular Diseases

oxyphenbutazone has been researched along with Cardiovascular Diseases in 2 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giannini, SD1
Sanchis, FS1
Guerra, JL1
Merusse, JL1
Jobin, F1

Reviews

1 review available for oxyphenbutazone and Cardiovascular Diseases

ArticleYear
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    L'union medicale du Canada, 1976, Volume: 105, Issue:8

    Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arterioscl

1976

Other Studies

1 other study available for oxyphenbutazone and Cardiovascular Diseases

ArticleYear
[Cardiovascular lesions induced in rats by vitamin D. Possible protective effect of sulfinpyrazone].
    Arquivos brasileiros de cardiologia, 1983, Volume: 41, Issue:3

    Topics: Animals; Arteries; Cardiovascular Diseases; Dipyridamole; Male; Myocardium; Necrosis; Oxyphenbutazon

1983